• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® FSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® FSH Back to Search Results
Catalog Number 30407
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
A customer in uruguay notified biomerieux that they observed underestimated results when testing quality control samples with vidas fsh 60 tests ¿ ref.30407, batch 1009124050, expiry date 03-dec-2022.The external qc sample was tested as part of the proficiency testing challenge (subscription 178963 / bche 432).The quality control is cecc.The results were the following: - sample a: 20.92 miu/ml; expected result 29.60 [22.2 - 37.0] miu/ml - sample b: 6.29 miu/ml; expected result 9.99 miu/ml [7.4 - 12.5] miu/ml the target values are the ones from the vidas peer group.There was no patient involved as it was external quality control samples.No further information were available at the time of this assessment.A biomérieux internal investigation will be initiated.Note: reference 30407 is not registered in the united states.The u.S.Similar device is product reference 30407-01.
 
Manufacturer Narrative
An internal investigation was performed following a notification from a customer in uruguay that they obtained underestimated results during proficiency testing challenge using vidas fsh 60 tests (ref.30407, lot 1009124050, expiry date 03-dec-2022).Investigation results: no material was received from the customer.1.Complaint analysis.At the date of investigation, no other complaints were recorded for underestimated results on vidas fsh 60 tests (ref.30407, lot 1009124050).2.Tests/analysis performed by complaints laboratory.2.1.Control chart analysis.This analysis was carried out on four (4) internal samples with respective targets at 8.24/ 9.15 / 21.6 / 27.8 miu/ml using seven (7) batches of vidas fsh including the customer¿s lot 1009124050.The analysis of the control charts showed that all results are within specifications and the lot mentioned by the customer is in the trend compared to the other lots.2.2.Tests performed on retained kits using internal samples.Biomérieux's complaints laboratory tested four (4) internal samples with targets at 8.24 / 9.15 / 21.6 / 27.8 miu/ml using the retained kits of vidas fsh lot 1009124050 (customer¿s lot) and vidas fsh lot 1009014410 (lot used as a reference).The internal samples' targets were close to the ones of the concerned quality control samples a and b from the customer's complaint (29.69 and 9.99 miu/ml).The results obtained complied to the expectations with no significant difference compared to the results observed before the batches' release.There was no observed evolution over time of the samples' activity between both lots.Conclusion: anomaly (underestimated results) was not reproduced when testing internal samples with targets close to the ones of the concerned quality control samples from the complaint.Without the concerned quality control samples available, the investigation could not be further pursued.Therefore, no obvious root cause explaining customer¿s results could be identified.The phenomena observed by the customer can be due to one or a combination of causes listed below: - quality control samples' processing by the customer (e.G reconstitution, stability, homogenisation, and handling).- calibration results.- establishment of the range and targets (very low number of participants).According to the data mentioned above, there is no reconsideration of the performances of vidas fsh lot 1009124050.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® FSH
Type of Device
VIDAS® FSH
Manufacturer (Section D)
BIOMERIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR  69280
Manufacturer (Section G)
BIOMÉRIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR   69280
Manufacturer Contact
dima amro
5 rue des aqueducs
craponne 69290
FR   69290
MDR Report Key15061479
MDR Text Key304790356
Report Number8020790-2022-00082
Device Sequence Number1
Product Code CGJ
Combination Product (y/n)N
Reporter Country CodeUY
PMA/PMN Number
K921746
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/03/2022
Device Catalogue Number30407
Device Lot Number1009124050
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/23/2022
Initial Date FDA Received07/19/2022
Supplement Dates Manufacturer Received08/01/2022
Supplement Dates FDA Received08/30/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-